EC Pharmacology And Toxicology

Child disease diagnosis is a difficult health care issue. According their ages, they are unable to express their illness, symptoms and physiological feeling to doctors. This may meet with falsified treatment and severe pharmaceutical consequence. More care should be paid for pediatric disease diagnosis and treatments. This editorial discusses this issue of child disease diagnosis and treatment progress possibly in upcoming decades.

 Keywords: Pediatrics; Clinic Symptoms, Disease Diagnosis, Biotechnology

1. Che JY and Lu DY. “Difficult issue for child diseases diagnosis treatment and drug development”. EC Pharmacology and Toxicology 13.1 (2025): 1-2.
2. Baig MT., et al. “Irrational antibiotic prescribing practice among children in critical care of tertiary hospitals”. Pakistan Journal of Pharmaceutical Sciences 30.4 (2017): 1483-1489.
3. Lu DY., et al. “Undesired neural side-effects of a drug, a chemical and genetic interrelated problem”. Central Nervous System Agents in Medicinal Chemistry 10.2 (2010): 108-112.
4. Batool A., et al. “Leveraging clinical pharmacy expertise for pediatric cardiology in low and middle-income country”. Pakistan Heart Journal 57.1 (2024): 71-74.
5. Lu DY and Lu TR. “Drug sensitivity testing, a unique drug selection strategy”. Advances in Biomarker Sciences and Technology 2 (2020): 59-66.
6. Lu DY., et al. “Individualized cancer therapy, future approaches”. Current Pharmacogenomics and Personalized Medicine 16.2 (2018): 156-163.
7. Lu DY., et al. “Perspectives of personalized cancer therapy”. Advances in Biotechnology and Microbiology 4.3 (2017): 555637.
8. Lu DY., et al. “Nursery education, capability and service promotion”. Open Access Journal of Nursing 2.3 (2019): 1-4.
9. Lu DY., et al. “Nursery education in schools, significance for career”. Biomedical Research and Reviews 2.2 (2019): 113.
10. Carini C and Seyhan AA. “Tribulations and future opportunities for artificial intelligence in precision medicine”. Journal of Translational Medicine 22.1 (2024): 411.
11. Lu DY., et al. “Nursery services advances, global campaign”. Nursing and Care Open Access Journal 11.1 (2025): 1-3.
12. Lu DY., et al. “Anticancer drug development, getting out from bottleneck”. International Journal of Molecular Biology 2.1 (2017): 28-33.
13. Lu DY., et al. “Anticancer drug development, system updating and global participation”. Current Drug Therapy 12.1 (2017): 37-45.